Bapiro, Tashinga E <br/><br/>
Artemisinin and thiabendazole are potent inhibitors of cytochrome P450 1A2 (CYP1A2) activity in humans.  [electronic resource] 

 -  European journal of clinical pharmacology  Nov 2005 
 - 755-61 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0031-6970 
<br/><br/><label>Standard No.: </label>10.1007/s00228-005-0037-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimalarials--pharmacology<br/>Antinematodal Agents--pharmacology<br/>Area Under Curve<br/>Artemisinins--pharmacology<br/>Caffeine--pharmacokinetics<br/>Chromatography, High Pressure Liquid<br/>Cytochrome P-450 CYP1A2--metabolism<br/>Cytochrome P-450 CYP1A2 Inhibitors<br/>Drug Interactions<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Male<br/>Mass Spectrometry<br/>Middle Aged<br/>Theophylline--metabolism<br/>Thiabendazole--metabolism